Postoperative leukopenia as an independent prognostic factor in gastric cancer patients.
Xiaofeng Chen(Ningbo University), Yongqian Shu(Jiangsu Province Hospital), Yongmei Yin(Nanjing Medical University), Fang Zhu(Jiangsu University), Shaohua He(Huaihua University), Yiqian Liu(Jiangsu Province Hospital), Jing Qian(Jiangsu Province Hospital), Dong Pei(Sun Yat-sen University), Yingying Qian(Nanjing Medical University), Oluf Dimitri Røe(Norwegian University of Science and Technology)
Cited by 1
Related Papers
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|743
Bevacizumab plus erlotinib in Chinese patients with untreated, EGFR-mutated, advanced NSCLC (ARTEMIS-CTONG1509): A multicenter phase 3 study
|Cancer Cell|2021|232
Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant Mesothelioma
|Journal of Clinical Oncology|2018|229
Shortlasting, Unilateral Neuralgiform Headache Attacks with Conjunctival Injection, Tearing, Sweating, and Rhinorrhea
|Cephalalgia|1989|226
Malignant pleural mesothelioma: history, controversy and future of a manmade epidemic
|European Respiratory Review|2015|188